WORK Medical Technology Group LTD (WOK)
Nasdaq: WOK · Surgical & Medical Instruments & Apparatus · Hangzhou · filing with the SEC since 2022
Income statement, as filed
In US dollars (USD), as filed; per-share figures in US dollars; share counts. The fiscal year ends in September.| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Period ending | Sep 30, 2025 | Sep 30, 2024 | Sep 30, 2023 | Sep 30, 2022 |
| Report filed | Jan 30, 2026 | Feb 14, 2025 | · | · |
| Revenue | 9,848,715 | 11,506,440 | 13,565,951 | 19,711,290 |
| Gross profit | 2,344,854 | 2,868,386 | 4,142,984 | 4,418,792 |
| Research and development | 435,311 | 302,511 | 301,644 | 183,900 |
| General and administrative | 2,327,352 | 4,558,041 | 1,861,728 | 2,563,879 |
| Total operating expenses | 4,840,914 | 6,913,571 | 3,730,757 | 3,780,464 |
| Interest expense | 503,519 | 557,571 | 392,741 | 352,968 |
| Interest and investment income | 181,682 | 11,727 | 25,417 | 1,969 |
| Other income (expense), net | 135,400 | 578,758 | -8,746 | -360,409 |
| Total non-operating income (expense) | 1,414,090 | 379,485 | -301,838 | 475,233 |
| Income before income taxes | -1,081,970 | -3,665,700 | 110,389 | 1,113,561 |
| Income tax expense | 119,053 | -125,291 | 47,006 | 169,435 |
| Net income including non-controlling interests | -1,201,023 | -3,540,409 | 63,383 | 944,126 |
| Net income to non-controlling interests | -128,356 | -48,091 | -48,647 | 78,916 |
| Net income | -1,072,667 | -3,492,318 | 112,030 | 865,210 |
| Earnings per share, basic | -0.04 | -0.27 | 0.01 | 0.07 |
| Earnings per share, diluted | -0.04 | -0.27 | 0.01 | 0.07 |
| Weighted average shares, basic | 28,983,269 | 12,705,011 | 12,500,000 | 12,500,000 |
| Weighted average shares, diluted | 28,983,269 | 12,705,011 | 12,500,000 | 12,500,000 |
As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.A dot is a line not tagged for that period. r restated by the company in a later report; b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.
What each line is, and the XBRL concept behind it
Revenue what customers paid for what it sold
us-gaap:RevenueFromContractWithCustomerIncludingAssessedTaxGross profit revenue less the cost of what it sold
us-gaap:GrossProfitResearch and development spent on inventing what it sells next
us-gaap:ResearchAndDevelopmentExpenseGeneral and administrative the cost of running the company itself
us-gaap:GeneralAndAdministrativeExpenseTotal operating expenses the running costs together
us-gaap:OperatingExpensesInterest expense what its borrowing cost
us-gaap:InterestExpenseNonoperatingInterest and investment income what its cash and investments earned
us-gaap:InvestmentIncomeInterestOther income (expense), net gains and costs outside the business
us-gaap:OtherNonoperatingIncomeExpenseTotal non-operating income (expense) everything outside the business, together
us-gaap:NonoperatingIncomeExpenseIncome before income taxes profit before tax
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterestIncome tax expense tax charged on the period's profit
us-gaap:IncomeTaxExpenseBenefitNet income including non-controlling interests the whole group's profit, minority holders' share included
us-gaap:ProfitLossNet income to non-controlling interests the share that belongs to minority holders
us-gaap:NetIncomeLossAttributableToNoncontrollingInterestNet income the profit or loss that belongs to the company's shareholders
us-gaap:NetIncomeLossEarnings per share, basic net income per share outstanding
us-gaap:EarningsPerShareBasicEarnings per share, diluted net income per share, counting every share that could be issued
us-gaap:EarningsPerShareDilutedWeighted average shares, basic the average count of shares outstanding
us-gaap:WeightedAverageNumberOfSharesOutstandingBasicWeighted average shares, diluted the average count with every share that could be issued
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding